Antimicrob Agents Chemother. 1994 Jun;38(6):1428-32.

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.

Source

Antiviral Therapeutic Research Unit, Wellcome Research Laboratories, Beckenham, United Kingdom.

Abstract

We have selected a human immunodeficiency virus type 1 (HIV-1) mutant strain with a moderate (sevenfold) level of resistance to the nucleoside analog 2',3'-didehydro-2',3'-dideoxythymidine (D4T or stavudine). After serial passage of the HXB2 strain of HIV-1 in MT4 cells, a novel mutation involving two nucleotide substitutions in codon 75 of the viral reverse transcriptase, altering valine to threonine, was seen. When introduced into a wild-type HIV-1 background by site-directed mutagenesis, the T-75 mutation conferred cross-resistance to the dideoxynucleosides dideoxyinosine and dideoxycytosine as well as to 2',3'-didehydro-2',3'-dideoxycytosine.

PMID:: 7522429; [PubMed - indexed for MEDLINE]
PMCID: PMC188226

Free PMC Article

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Related citations

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. [Proc Natl Acad Sci U S A. 1993]
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M, Kemp SD, Parry NR, Larder BA. Proc Natl Acad Sci U S A. 1993 Jun 15; 90(12):5653-6.
Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. [AIDS Res Hum Retroviruses. 1994]
Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
Nájera I, Richman DD, Olivares I, Rojas JM, Peinado MA, Perucho M, Nájera R, López-Galíndez C. AIDS Res Hum Retroviruses. 1994 Nov; 10(11):1479-88.
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. [J Virol. 1992]
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA. J Virol. 1992 Dec; 66(12):7128-35.
Review Mechanisms of HIV-1 nucleoside reverse transcriptase inhibitor resistance: is it all figured out? [Curr Opin Investig Drugs. 2001]
Review Mechanisms of HIV-1 nucleoside reverse transcriptase inhibitor resistance: is it all figured out?
Naeger LK, Miller MD. Curr Opin Investig Drugs. 2001 Mar; 2(3):335-9.
Review Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding. [Curr Opin Biotechnol. 1994]
Review Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.
Beard WA, Wilson SH. Curr Opin Biotechnol. 1994 Aug; 5(4):414-21.

See reviews... See all...

Cited by 28 PubMed Central articles

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase. [Viruses. 2010]
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.
Singh K, Marchand B, Kirby KA, Michailidis E, Sarafianos SG. Viruses. 2010 Feb 11; 2(2):606-638.
Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination. [J Biol Chem. 2009]
Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.
Matamoros T, Nevot M, Martínez MA, Menéndez-Arias L. J Biol Chem. 2009 Nov 20; 284(47):32792-802. Epub 2009 Sep 29.
Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase. [J Biol Chem. 2009]
Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.
Tchesnokov EP, Obikhod A, Massud I, Lisco A, Vanpouille C, Brichacek B, Balzarini J, McGuigan C, Derudas M, Margolis L, et al. J Biol Chem. 2009 Aug 7; 284(32):21496-504. Epub 2009 Jun 9.

See all...

Chemical compound information

Stavudine

MW: 224.21 g/mol

MF: C₁₀H₁₂N₂O₄

See 242 citations for this compound....

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcripta...
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.
Antimicrob Agents Chemother. 1994 Jun ;38(6):1428-32.

PubMed
Doctors need union representation.
Doctors need union representation.
N Engl J Med. 1981 Aug 27 ;305(9):525.

PubMed
Telomeres and mechanisms of Robertsonian fusion.
Telomeres and mechanisms of Robertsonian fusion.
Chromosoma. 1998 May ;107(2):136-40.

PubMed
The Charles Bonnet syndrome: 'phantom visual images'.
The Charles Bonnet syndrome: 'phantom visual images'.
Perception. 1991 ;20(6):809-25.

PubMed
Endocervicosis of the urinary bladder. A report of six cases of a benign mülleri...
Endocervicosis of the urinary bladder. A report of six cases of a benign müllerian lesion that may mimic adenocarcinoma.
Am J Surg Pathol. 1992 Jun ;16(6):533-42.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 28 PubMed Central articles

Chemical compound information

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information